LICENSE AGREEMENTLicense Agreement • June 22nd, 2018 • Aptose Biosciences Inc. • Biological products, (no disgnostic substances) • New York
THIS LICENSE AGREEMENT (this “Agreement”) is made as of June 13, 2018 (the “Effective Date”) by and between APTOSE BIOSCIENCES INC., a Canadian corporation (“Aptose”), having a place of business at 251 Consumers Road, Suite 1105, Toronto, Ontario, M2J 4R3, Canada, and CRYSTALGENOMICS, INC., a South Korean corporation (“CG”), having a place of business at 5th F. Bldg. A, Korea Bio Park, 700 Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13488 Korea. Aptose and CG are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
